Published in Naunyn Schmiedebergs Arch Pharmacol on June 06, 2010
Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits. Mol Neurodegener (2013) 0.88
Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task. Psychopharmacology (Berl) (2013) 0.87
Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms. Int J Neuropsychopharmacol (2014) 0.84
Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens. Mol Psychiatry (2013) 0.84
Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. J Neurosci (2013) 0.82
Disrupted-in-schizophrenia-1 Gln31Leu polymorphism results in social anhedonia associated with monoaminergic imbalance and reduction of CREB and β-arrestin-1,2 in the nucleus accumbens in a mouse model of depression. Neuropsychopharmacology (2012) 0.80
The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology (Berl) (2014) 0.78
Rodent models of treatment-resistant depression. Eur J Pharmacol (2014) 0.75
Bupropion and Citalopram in the APP23 Mouse Model of Alzheimer's Disease: A Study in a Dry-Land Maze. Int J Alzheimers Dis (2012) 0.75
Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol (1999) 1.56
Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol (1991) 1.46
Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Arch Gen Psychiatry (1976) 1.38
Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl) (2008) 1.21
Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology (Berl) (1994) 1.06
The mesolimbic dopamine system as a target for rapid antidepressant action. Int Clin Psychopharmacol (1997) 1.04
Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther (1980) 1.02
Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats. Neuropharmacology (2002) 0.97
Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression. J Affect Disord (2000) 0.92
Ropinirole in treatment-resistant depression: a 16-week pilot study. Can J Psychiatry (2005) 0.92
Effect of bupropion on hippocampal neurotransmitters and on peripheral hormonal concentrations in the rat. J Appl Physiol (1985) (2003) 0.92
In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Synapse (1994) 0.88
Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. Eur J Pharmacol (2004) 0.86
Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression. Biol Psychiatry (1996) 0.86
Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens. J Pharm Pharmacol (1988) 0.84
Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test. Pharmacol Biochem Behav (2002) 0.83
Depressant-like effects of parthenolide in a rodent behavioural antidepressant test battery. J Pharm Pharmacol (2008) 0.83
Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants. Brain Res (1990) 0.81
In vivo occupancy of D2 dopamine receptors by nafadotride. Neuropsychopharmacology (1997) 0.79
Switching to bupropion in fluoxetine-resistant major depressive disorder. Ann Clin Psychiatry (2003) 0.78
Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.77
Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming test. Neuropharmacology (1987) 0.77
[Strategy to develop a new drug for treatment-resistant depression--role of electroconvulsive stimuli and BDNF]. Yakugaku Zasshi (2007) 0.77
Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding--an autoradiographic analysis. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.77
Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain. Eur J Pharmacol (1996) 0.76
Anxiolytic- and antidepressant-like effects of 7-OH-DPAT, preferential dopamine D3 receptor agonist, in rats. Pol J Pharmacol (2004) 0.76
Effects of imipramine and bupropion on the duration of immobility of ACTH-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA. Biol Pharm Bull (2008) 0.75
Comparative study of increased plasma quinidine concentration in rats with glycerol- and cisplatin-induced acute renal failure. Drug Metab Pharmacokinet (2009) 1.41
Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. Proc Natl Acad Sci U S A (2007) 1.15
Effects of HMGB1 on ischemia-reperfusion injury in the rat heart. Circ J (2008) 1.14
Royal jelly ameliorates insulin resistance in fructose-drinking rats. Biol Pharm Bull (2008) 1.12
Pericentrin, a centrosomal protein related to microcephalic primordial dwarfism, is required for olfactory cilia assembly in mice. FASEB J (2009) 1.11
DISC1 localizes to the centrosome by binding to kendrin. Biochem Biophys Res Commun (2004) 1.08
Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules. FASEB J (2006) 1.07
Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells. Biochim Biophys Acta (2003) 1.03
CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects. Life Sci (2004) 1.03
Dopaminergic neuron-specific oxidative stress caused by dopamine itself. Acta Med Okayama (2008) 1.02
Lithium treatment elongates primary cilia in the mouse brain and in cultured cells. Biochem Biophys Res Commun (2009) 1.00
Characterization of pericentrin isoforms in vivo. Biochem Biophys Res Commun (2006) 1.00
Neuronal nitric-oxide synthase inhibition facilitates adrenergic neurotransmission in rat mesenteric resistance arteries. J Pharmacol Exp Ther (2005) 0.96
Parkin attenuates manganese-induced dopaminergic cell death. J Neurochem (2004) 0.96
Beneficial Effects of Fermented Green Tea Extract in a Rat Model of Non-alcoholic Steatohepatitis. J Clin Biochem Nutr (2009) 0.96
Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity. Glia (2010) 0.96
Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity. Int Rev Neurobiol (2009) 0.96
Approaches to prevent dopamine quinone-induced neurotoxicity. Neurochem Res (2008) 0.94
Prednisolone inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension. Circulation (2005) 0.93
Embryonic expression of pericentrin suggests universal roles in ciliogenesis. Dev Genes Evol (2006) 0.93
Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia. Brain Res (2004) 0.92
Factors that influence primary cilium length. Acta Med Okayama (2011) 0.92
Vanilloid receptors mediate adrenergic nerve- and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries. Br J Pharmacol (2004) 0.90
[Effect of propolis on insulin resistance in fructose-drinking rats]. Yakugaku Zasshi (2007) 0.89
Histamine-induced vasodilation and vasoconstriction in the mesenteric resistance artery of the rat. Eur J Pharmacol (2005) 0.88
L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease. J Neurol (2005) 0.87
Regulation of ghrelin secretion during pregnancy and lactation in the rat: possible involvement of hypothalamus. Peptides (2004) 0.87
Neuronal nicotinic receptor and psychiatric disorders: functional and behavioral effects of nicotine. Jpn J Pharmacol (2002) 0.87
Hyperinsulinemia induces hypertension associated with neurogenic vascular dysfunction resulting from abnormal perivascular innervations in rat mesenteric resistance arteries. Hypertens Res (2011) 0.87
Increased susceptibility to oxidant-mediated tissue injury and peritoneal fibrosis in acatalasemic mice. Am J Nephrol (2008) 0.87
Anti-oxidative and anti-inflammatory effects of spirulina on rat model of non-alcoholic steatohepatitis. J Clin Biochem Nutr (2012) 0.87
Targeting 5-HT(1A) receptors in astrocytes to protect dopaminergic neurons in Parkinsonian models. Neurobiol Dis (2013) 0.85
Antidepressant-like action of nicotine in forced swimming test and brain serotonin in mice. Physiol Behav (2006) 0.85
Effects of physical and psychological stress on 5-HT2A receptor-mediated wet-dog shake responses in streptozotocin-induced diabetic rats. Acta Med Okayama (2007) 0.84
Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test. Pharmacol Biochem Behav (2002) 0.83
Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats. Diabetes (2012) 0.83
Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen. Neurochem Res (2008) 0.83
The p53-activated gene, PAG608, requires a zinc finger domain for nuclear localization and oxidative stress-induced apoptosis. J Biol Chem (2002) 0.83
Nicotine blocks apomorphine-induced disruption of prepulse inhibition of the acoustic startle in rats: possible involvement of central nicotinic alpha7 receptors. Br J Pharmacol (2004) 0.83
Direct evidence for increased hydroxyl radicals in angiotensin II-induced cardiac hypertrophy through angiotensin II type 1a receptor. J Cardiovasc Pharmacol (2003) 0.83
Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure. Psychopharmacology (Berl) (2004) 0.83
Repeated electroconvulsive stimuli increase brain-derived neurotrophic factor in ACTH-treated rats. Eur J Pharmacol (2005) 0.82
Beneficial effects of Vitis coignetiae Pulliat leaves on nonalcoholic steatohepatitis in a rat model. Acta Med Okayama (2009) 0.82
A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH. J Clin Biochem Nutr (2009) 0.82
Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes. Biochem Pharmacol (2006) 0.82
Protective effects of phytochemical antioxidants against neurotoxin-induced degeneration of dopaminergic neurons. J Pharmacol Sci (2014) 0.82
The mechanism of calcitonin gene-related peptide-containing nerve innervation. J Pharmacol Sci (2012) 0.82
Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells. Biochem Biophys Res Commun (2005) 0.81
Investigation of the release behavior of a covered-rod-type formulation using silicone. J Control Release (2003) 0.81
Oxidation of 5-methoxy-N,N-diisopropyltryptamine in rat liver microsomes and recombinant cytochrome P450 enzymes. Biochem Pharmacol (2007) 0.81
Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats. Br J Pharmacol (2005) 0.81
[Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats]. Yakugaku Zasshi (2008) 0.81
Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity. FEBS Lett (2007) 0.81
Involvement of STAT3 in bladder smooth muscle hypertrophy following bladder outlet obstruction. Acta Med Okayama (2006) 0.81
Effect of valerian extract preparation (BIM) on the sleep-wake cycle in rats. Biol Pharm Bull (2007) 0.80
Effects of some H1-antagonists on the sleep-wake cycle in sleep-disturbed rats. J Pharmacol Sci (2007) 0.80
Endothelial modulation of agonist-induced vasoconstriction in mesenteric microcirculation. Yakugaku Zasshi (2010) 0.80
Participation of histaminergic H1 and noradrenergic alpha 1 receptors in orexin A-induced wakefulness in rats. Brain Res (2004) 0.80
Chronic hyperinsulinemia enhances adrenergic vasoconstriction and decreases calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats. Hypertens Res (2006) 0.80
Comparative study on altered hepatic metabolism of CYP3A substrates in rats with glycerol-induced acute renal failure. Biopharm Drug Dispos (2012) 0.80
Imipramine-induced c-Fos expression in the medial prefrontal cortex is decreased in the ACTH-treated rats. J Biochem Mol Toxicol (2013) 0.80
[Interaction of 5-HT and HPA axis in depression and treatment-resistant depression]. Nihon Yakurigaku Zasshi (2002) 0.80
Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence. Behav Brain Res (2005) 0.80
Regulatory role of the dopamine and norepinephrine transporters in pentylenetetrazol-kindled mice: association with effect of antidepressants. Eur J Pharmacol (2011) 0.80
[Effect of santalol on the sleep-wake cycle in sleep-disturbed rats]. Nihon Shinkei Seishin Yakurigaku Zasshi (2007) 0.80
New molecular mechanisms for cardiovascular disease: contribution of endothelium-derived hyperpolarizing factor in the regulation of vasoconstriction in peripheral resistance arteries. J Pharmacol Sci (2011) 0.80
Effect of heat exposure on aminophylline-induced convulsions in mice. Biol Pharm Bull (2011) 0.80
Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity. Toxicol Lett (2008) 0.80
Molecular basis of 6-hydroxydopamine-induced caspase activations due to increases in oxidative stress in the mouse striatum. Neurosci Lett (2006) 0.80
R-(-)-alpha-methylhistamine, a histamine H3 receptor agonist, induces endothelium-dependent vasodilation in rat mesenteric resistance arteries. Biol Pharm Bull (2010) 0.80
Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice. Am J Physiol Renal Physiol (2013) 0.80
Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats. Psychopharmacology (Berl) (2003) 0.80
Nerve growth factor suppresses prostate tumor growth. J Pharmacol Sci (2010) 0.80
Adrenergic stimulation-released 5-HT stored in adrenergic nerves inhibits CGRPergic nerve-mediated vasodilatation in rat mesenteric resistance arteries. Br J Pharmacol (2012) 0.79
[Effect of long-term treatment with royal jelly on insulin resistance in Otsuka Long-Evans Tokushima Fatty (OLETF) rats]. Yakugaku Zasshi (2007) 0.79
Altered function of nitrergic nerves inhibiting sympathetic neurotransmission in mesenteric vascular beds of renovascular hypertensive rats. Hypertens Res (2010) 0.79
Induction of parkinsonism-related proteins in the spinal motor neurons of transgenic mouse carrying a mutant SOD1 gene. J Neurosci Res (2010) 0.79
Effect of aripiprazole on 5-HT2 receptor-mediated wet-dog shake responses and disruption of prepulse inhibition in rats. J Pharmacol Sci (2008) 0.79
Anandamide induces endothelium-dependent vasoconstriction and CGRPergic nerve-mediated vasodilatation in the rat mesenteric vascular bed. J Pharmacol Sci (2012) 0.79
Effects of drugs acting on the GABA-benzodiazepine receptor complex on flurothyl-induced seizures in Mongolian gerbils. Eur J Pharmacol (2006) 0.79
Effects of imipramine and lithium on wet-dog shakes mediated by the 5-HT2A receptor in ACTH-treated rats. Pharmacol Biochem Behav (2002) 0.79
High glucose increases metallothionein expression in renal proximal tubular epithelial cells. Exp Diabetes Res (2011) 0.79
Dopamine induces supernumerary centrosomes and subsequent cell death through Cdk2 up-regulation in dopaminergic neuronal cells. Neurotox Res (2008) 0.79
Changes of sleep patterns in rats with chronic constriction injury under aversive conditions. Biol Pharm Bull (2007) 0.79
Molecular basis of anti-apoptotic effect of immunophilin ligands on hydrogen peroxide-induced apoptosis in human glioma cells. Neurochem Res (2004) 0.79
Effluent free radicals are associated with residual renal function and predict technique failure in peritoneal dialysis patients. Perit Dial Int (2012) 0.79
Different prostanoids are involved in bradykinin-induced endothelium-dependent and -independent vasoconstriction in rat mesenteric resistance arteries. J Pharmacol Sci (2004) 0.79
The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure. Brain Res (2005) 0.79
Effects of galantamine on L-NAME-induced behavioral impairment in Y-maze task in mice. Neurosci Lett (2009) 0.78
Specific induction of PAG608 in cranial and spinal motor neurons of L-DOPA-treated parkinsonian rats. Neurosci Res (2007) 0.78
Nicotinic acetylcholine alpha4beta2 receptor regulates the motivational effect of intracranial self stimulation behavior in the runway method. J Pharmacol Sci (2008) 0.78
Rotenone induces disassembly of the Golgi apparatus in the rat dopaminergic neuroblastoma B65 cell line. Neurosci Lett (2004) 0.78